Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial

被引：1

作者：

Scheffold, Annika ^{[1
]}

Jebaraj, Billy Michael Chelliah ^{[1
]}

Jaramillo, Sonia ^{[1
]}

Tausch, Eugen ^{[1
]}

Steinbrecher, Daniela ^{[1
]}

Hahn, Michael ^{[2
]}

Boettcher, Sebastian ^{[3
]}

Ritgen, Matthias ^{[3
]}

Bunjes, Donald ^{[1
]}

Zeis, Matthias ^{[4
]}

Stadler, Michael ^{[5
]}

Uharek, Lutz ^{[6
]}

Scheid, Christoph ^{[7
]}

Hegenbart, Ute ^{[2
]}

Hallek, Michael ^{[7
]}

Kneba, Michael ^{[3
]}

Schmitz, Norbert ^{[4
]}

Doehner, Hartmut ^{[1
]}

Dreger, Peter ^{[2
]}

Stilgenbauer, Stephan ^{[1
]}

机构：

[1] Univ Ulm, Dept Internal Med 3, Ulm, Germany

[2] Heidelberg Univ, Dept Med 5, Heidelberg, Germany

[3] Univ Med Ctr Schleswig Holstein, Dept Med 2, Kiel, Germany

[4] Asklepios Klin St Georg, Dept Haematol & Stem Cell Transplantat, Hamburg, Germany

[5] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, Hannover, Germany

[6] Univ Med Berlin, Charite Campus Virchow Klinikum, Dept Med Haematol Oncol & Tumour Immunol, Berlin, Germany

[7] Univ Cologne, Dept Med 1, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 179卷 / 02期

关键词：

Chronic lymphocytic leukaemia; Telomere length; Allogeneic stem cell transplantation; ABERRATIONS; DISEASE;

D O I：

10.1111/bjh.14219

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：342 / 346

页数：5

共 50 条

[21] Efficacy and prognostic implications of early autologous stem cell transplantation for poor-risk chronic lymphocytic leukemia (CLL).
Dreger, P
von Neuhoff, N
Sonnen, R
Kuse, R
Seyfarth, B
Lorenz, G
Glass, B
Schmitz, N
[J]. BLOOD, 2000, 96 (11) : 483A - 483A
[22] Fludarabine with cytarabine and sequential reduced-intensity conditioning with allogeneic stem cell transplantation in 15 patients with poor-risk chronic lymphocytic leukaemia
Krejci, M.
Doubek, M.
Brychtova, Y.
Koristek, Z.
Stehlikova, O.
Chovancova, J.
Kuhrova, S.
Francova, H.
Tichy, B.
Navratil, M.
Tomiska, M.
Horky, O.
Mayer, J.
[J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S419 - S420
[23] Allogeneic stem cell transplantation for poor-risk CLL using Fludarabine/Cyclophosphamide (FC) conditioning
Dreger, P
Stilgenbauer, S
Truemper, L
Humpe, A
Glass, B
Seyfarth, B
von Neuhoff, N
Schoch, R
Schmitz, N
Döhner, H
[J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S37 - S37
[24] Outcome Of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
Benjamini, Ohad
Rozovski, Uri
Jain, Preetesh
Wierda, William G.
O'Brien, Susan
Burger, Jan A.
Ferrajoli, Alessandra
Faderl, Stefan H.
Shpall, Elizabeth J.
Hosing, Chitra M.
Khouri, Issa F.
Champlin, Richard E.
Keating, Michael J.
Estrov, Zeev
[J]. BLOOD, 2013, 122 (21)
[25] Outcome of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
Benjamini, Ohad
Rozovski, Uri
Jain, Preetesh
Wierda, William G.
O'Brien, Susan
Burger, Jan
Ferrajoll, Alessandra
Faderl, Stefan
Shpall, Elizabeth
Hosing, Chitra
Khouri, Issa F.
Champlin, Richard
Keating, Michael J.
Estrov, Zeev
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S130 - S131
[26] Long-term disease control of poor-risk chronic lymphocytic leukemia (CLL) by allogeneic stem cell transplantation with nonmyeloablative conditioning (NST):: Interim results of a prospective study
Dreger, P
Stilgenbauer, S
Boettcher, S
Bunjes, D
Ottinger, H
Beelen, D
Cohen, S
Schubert, J
Hertenstein, B
Basara, N
Humpe, A
Ritgen, M
Zeis, M
Schmitz, N
Hallek, M
Kneba, M
Döhner, H
[J]. ANNALS OF ONCOLOGY, 2005, 16 : 43 - 44
[27] SF3B1, NOTCH1 and TP53 Mutations Do Not Affect the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 6-Year Follow-up of the Gcllsg CLL3X Trial
Dreger, Peter
Schnaiter, Andrea
Rossi, Marianna
Paschka, Peter
Buehler, Andreas
Zenz, Thorsten
Dietrich, Sascha
Boettcher, Sebastian
Bunjes, Donald
Stadler, Michael
Uharek, Lutz
Scheid, Christof
Hegenbart, Ute
Hallek, Michael
Kneba, Michael
Schmitz, Norbert
Doehner, Hartmut
Stilgenbauer, Stephan
[J]. BLOOD, 2012, 120 (21)
[28] Past informs the future: outcomes post allogeneic stem cell transplantation in high risk chronic lymphocytic leukaemia (CLL)
Bennett, Rory
Frawley, Thomas
Khot, Amit
Thompson, Phillip
Anderson, Mary Ann
Ritchie, David
[J]. LEUKEMIA & LYMPHOMA, 2023, 64 : S153 - S154
[29] Practical Aspects of Allogeneic Hematopoietic Cell Transplantation for Patients with Poor-Risk Chronic Lymphocytic Leukemia
Delgado, Julio
Duarte, Rafael F.
[J]. THESCIENTIFICWORLDJOURNAL, 2011, 11 : 161 - 172
[30] Allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukemia using reduced-intensity conditioning: interim results of a prospective study
Dreger, P
Stilgenbauer, S
Bunjes, D
Humpe, A
Ritgen, M
Seyfarth, B
Truemper, L
Kneba, M
Schmitz, N
Doehner, H
[J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S56 - S56

← 1 2 3 4 5 →